Comprehensive review of epidemiological and animal studies on the potential carcinogenic effects of nicotine per se

References

• Al-Wadei HAN, Al-Wadei MH, Ullah MF, Schuller HM. 2012. Gamma-amino butyric acid inhibits the nicotine-imposed stimulatory challenge in xenograft models of non-small cell lung carcinoma. Curr Cancer Drug Targets. 12:97–106.
   PubMed Web of Science ®Google Scholar
• Al-Wadei HAN, Plummer HK III, Schuller HM. 2009. Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter γ-aminobutyric acid. Carcinogenesis. 30:506–511.
   PubMed Web of Science ®Google Scholar
• Alexander DJ, Collins CJ, Coombs DW, Gilkison IS, Hardy CJ, Healey G, Karantabias G, Johnson N, Karlsson A, Kilgour JD, et al. 2008. Association of Inhalation Toxicologists (AIT) working party recommendation for standard delivered dose calculation and expression in non-clinical aerosol inhalation toxicology studies with pharmaceuticals. Inhal Toxicol. 20:1179–1189.
   PubMed Web of Science ®Google Scholar
• AlSharari SD, Akbarali HI, Abdullah RA, Shahab O, Auttachoat W, Ferreira GA, White KL, Lichtman AH, Cabral GA, Damaj MI. 2013. Novel insights on the effect of nicotine in a murine colitis model. J Pharmacol Exp Ther. 344:207–217.
   PubMed Web of Science ®Google Scholar
• Arany I, Grifoni S, Clark JS, Csongradi E, Maric C, Juncos LA. 2011. Chronic nicotine exposure exacerbates acute renal ischemic injury. Am J Physiol Renal Physiol. 301:F125–F133.
   Google Scholar
• Argentin G, Cicchetti R. 2004 Genotoxic and antiapoptotic effect of nicotine on human gingival fibroblasts. Toxicol Sci. 79:75–81.
   PubMed Web of Science ®Google Scholar
• Banerjee J, Al-Wadei HA, Al-Wadei MH, Dagnon K, Schuller HM. 2014. Differential modulation of nicotine-induced gemcitabine resistance by GABA receptor agonists in pancreatic cancer cell xenografts and in vitro. BMC Cancer. 14:725.
   PubMed Web of Science ®Google Scholar
• Banerjee J, Al-Wadei HAN, Schuller HM. 2013. Chronic nicotine inhibits the therapeutic effects of gemcitabine on pancreatic cancer in vitro and in mouse xenografts. Eur J Cancer. 49:1152–1158.
   PubMed Web of Science ®Google Scholar
• Bavarva JH, Tae H, McIver L, Garner HR. 2014. Nicotine and oxidative stress induced exomic variations are concordant and overrepresented in cancer-associated genes. Oncotarget. 5:4788–4798.
   PubMed Web of Science ®Google Scholar
• Benowitz NL. 2011. Smokeless tobacco as a nicotine delivery device: harm or harm reduction? Clin Pharmacol Ther. 90:491–493.
   PubMed Web of Science ®Google Scholar
• Benowitz NL. 2014. Emerging nicotine delivery products. Implications for public health. Ann Am Thorac Soc. 11:231–235.
   PubMedGoogle Scholar
• Benowitz NL, Hukkanen J, Jacob P III. 2009. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol. 192:29–60.
   PubMedGoogle Scholar
• Berger MR, Zeller WJ. 1988. Interaction of nicotine with anticancer treatment. Klin Wochenschr. 66: 127–133.
   PubMedGoogle Scholar
• Bersch VP, Osvaldt AB, Edelweiss MI, Schumacher RC, Wendt LR, Abreu LP, Blom CB, Abreu GP, Costa L, Piccinini P, et al. 2009. Effect of nicotine and cigarette smoke on an experimental model of intraepithelial lesions and pancreatic adenocarcinoma induced by 7,12-dimethylbenzanthracene in mice. Pancreas. 38:65–70.
   PubMed Web of Science ®Google Scholar
• Bhagat B, Rana MW. 1971. Antitumor activity of antiserum nerve growth factor (anti-NGF). Proc Soc Exp Biol Med. 138:983–984.
   PubMed Web of Science ®Google Scholar
• Bock FG. 1980. Cocarcinogenic properties of nicotine. In: Gori GB, Bock FG, editors. A safe cigarette? Cold Spring Harbor (NY): Cold Spring Harbor Laboratory. p. 129–136.
   Google Scholar
• Bock FG, Tso TC. 1976. Chemical and biological identification of tumorigenic components of tobacco. In: Wynder EL, Hoffmann D, Gori GB, editors. Proceedings of the third world conference on smoking and health. Washington (DC): Government Printing Office. p. 161–174.
   Google Scholar
• Boyland E. 1968. The possible carcinogenic action of alkaloids of tobacco and betel nut. Planta Med. 1968:13–23.
   Google Scholar
• Brown KC, Perry HE, Lau JK, Jones DV, Pulliam JF, Thornhill BA, Crabtree CM, Luo H, Chen YC, Dasgupta P. 2013. Nicotine induces the up-regulation of the α7-nicotinic receptor (α7-nAChR) in human squamous cell lung cancer cells via the Sp1/GATA protein pathway. J Biol Chem. 288:33049–33059.
   PubMed Web of Science ®Google Scholar
• Cardinale A, Nastrucci C, Cesario A, Russo P. 2012. Nicotine: specific role in angiogenesis, proliferation and apoptosis. Crit Rev Toxicol. 42:68–89.
   PubMed Web of Science ®Google Scholar
• Chen YP, Johnson GK, Squier CA. 1994. Effects of nicotine and tobacco-specific nitrosamines on hamster cheek pouch and gastric mucosa. J Oral Pathol Med. 23:251–255.
   PubMed Web of Science ®Google Scholar
• Chen YP, Squier CA. 1990. Effect of nicotine on 7,12-dimethylbenz[a]anthracene carcinogenesis in hamster cheek pouch. J Natl Cancer Inst. 82:861–864.
   PubMedGoogle Scholar
• Cheng SY, Glazkova D, Serova Sabban EL. 2005. Effect of prolonged nicotine infusion on response of rat catecholamine biosynthetic enzymes to restraint and cold stress. Pharmacol Biochem Behav. 82:559–568.
   PubMed Web of Science ®Google Scholar
• Chu KM, Cho CH, Shin VY. 2013. Nicotine and gastrointestinal disorders: its role in ulceration and cancer development. Curr Pharm Des. 19:5–10.
   PubMed Web of Science ®Google Scholar
• Clayson DB. 1974. Editorial: bladder carcinogenesis in rats and mice: possibility of artifacts. J Natl Cancer Inst. 52:1685–1689.
   PubMed Web of Science ®Google Scholar
• Cohen SM, Ellwein LB. 1991. Genetic errors, cell proliferation, and carcinogenesis. Cancer Res. 51:6493–6505.
   PubMed Web of Science ®Google Scholar
• Davis R, Rizwani W, Banerjee S, Kovacs M, Haura E, Coppola D, Chellappan S. 2009. Nicotine promotes tumor growth and metastasis in mouse models of lung cancer. PLoS One. 4:e7524.
   PubMedGoogle Scholar
• Demirhan O, Demir C, Tunc E, nandiklioglu N, Sutcu E, Sadikoglu N, Ozcan B. 2011. The genotoxic effect of nicotine on chromosomes of human fetal cells: the first report described as an important study. Inhal Toxicol. 23:829–834.
   PubMed Web of Science ®Google Scholar
• Dinse GE, Peddada SD, Harris SF, Elmore SA. 2010. Comparison of NTP historical control tumor incidence rates in female Harlan Sprague Dawley and Fischer 344/N Rats. Toxicol Pathol. 38:765–775.
   PubMed Web of Science ®Google Scholar
• Doolittle DJ, Winegar R, Lee CK, Caldwell WS, Hayes AW, de Bethizy JD. 1995. The genotoxic potential of nicotine and its major metabolites. Mutat Res. 344:95–102.
   PubMed Web of Science ®Google Scholar
• Eränkö O, Hopsu V, Räisäinen L. 1959a. Changes induced by prolonged administration of nicotine in the distributions of cholinesterases and acid phosphatase in the adrenal medulla of the rat. J Neurochem. 4:332–337.
   PubMed Web of Science ®Google Scholar
• Eränkö O, Hopsu V, Räisäinen L. 1959b. Effect of prolonged administration nicotine on the medullary volume and the distribution of noradrenaline in the adrenals of the rat, the mouse and the guinea pig. Endocrinology. 65:293–297.
   PubMed Web of Science ®Google Scholar
• Feng S, Kapur S, Sarkar M, Muhammad R, Mendes P, Newland K, Roethig HJ. 2007. Respiratory retention of nicotine and urinary excretion of nicotine and its five major metabolites in adult male smokers. Toxicol Lett. 173:101–106.
   PubMed Web of Science ®Google Scholar
• Flora JW, Meruva N, Huang CB, Wilkinson CT, Ballentine R, Smith DC, Werley MS, McKinney WJ. 2016. Characterization of potential impurities and degradation products in electronic cigarette formulations and aerosols. Regul Toxicol Pharmacol. 74:1–11.
   PubMed Web of Science ®Google Scholar
• Freedlander BL, French FA. 1956. Absence of co-carcinogenic action of oxidation products of nicotine in initiation of pulmonary adenomas in mice with urethane. Proc Am Assoc Cancer Res. 2:109.
   Google Scholar
• Freedlander BL, French FA, Furst A. 1956. The nonadditive effect of nicotine and nicotine N-oxide on the carcinogenicity of ultraviolet light. Proc Am Assoc Cancer Res. 2:109.
   Google Scholar
• Fucito LM, Bars MP, Forray A, Rojewski AM, Shiffman S, Selby P, West R, Foulds J, Toll BA. Writing Committee for the SRNT Policy and Treatment Networks. 2014. Addressing the evidence for FDA nicotine replacement therapy label changes: a policy statement of the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco. Nicotine Tob Res. 16:909–914.
   PubMed Web of Science ®Google Scholar
• Galitovskiy V, Chernyavsky AI, Edwards RA, Grando SA. 2012. Muscle sarcomas and alopecia in A/J mice chronically treated with nicotine. Life Sci. 91:1109–1112.
   PubMed Web of Science ®Google Scholar
• Gaworski CL, Lemus-Olalde R, Carmines EL. 2008. Toxicological evaluation of potassium sorbate added to cigarette tobacco. Food Chem Toxicol. 46:339–351.
   PubMed Web of Science ®Google Scholar
• Ginzkey C, Steussloff G, Koehler C, Burghartz M, Scherzed A, Hackenberg S, Hagen R, Kleinsasser NH. 2014a. Nicotine derived genotoxic effects in human primary parotid gland cells as assessed in vitro by comet assay, cytokinesis-block micronucleus test and chromosome aberrations test. Toxicol in Vitro. 28:838–846.
   PubMed Web of Science ®Google Scholar
• Ginzkey C, Steussloff G, Koehler C, Hackenberg S, Richter E, Hagen R, Kleinsasser NH. 2014b. Nicotine causes genotoxic damage but is not metabolized during long-term exposure of human nasal miniorgan cultures. Toxicol Lett. 229:303–310.
   PubMed Web of Science ®Google Scholar
• Ginzkey C, Stueber T, Friehs G, Koehler C, Hackenberg S, Richter E, Hagen R, Kleinsasser NH. 2012. Analysis of nicotine-induced DNA damage in cells of the human respiratory tract. Toxicol Lett. 208:23–29.
   PubMed Web of Science ®Google Scholar
• Ginzkey C, Friehs G, Koehler C, Hackenberg S, Hagen R, Kleinsasser NH. 2013. Assessment of nicotine-induced DNA damage in a genotoxicological test battery. Mutat Res Genet Toxicol Environ Mutagen. 751:34–39.
   PubMed Web of Science ®Google Scholar
• Goodman JE, Prueitt RL, Sax SN, Bailey LA, Rhomberg LR. 2013. Evaluation of the causal framework used for setting national ambient air quality standards. Crit Rev Toxicol. 43:829–849.
   PubMed Web of Science ®Google Scholar
• Goodman JE, Prueitt RL, Sax SN, Lynch HN, Zu K, Lemay JC, King JM, Venditti FJ. 2014. Weight-of-evidence evaluation of short-term ozone exposure and cardiovascular effects. Crit Rev Toxicol. 44:725–790.
   PubMed Web of Science ®Google Scholar
• Grabus SD, Martin BR, Batman AM, Tyndale RF, Sellers E, Damaj MI. 2005. Nicotine physical dependence and tolerance in the mouse following chronic oral administration. Psychopharmacology (Berlin). 178:183–192.
   PubMed Web of Science ®Google Scholar
• Grando SA. 2014. Connections of nicotine to cancer. Nat Rev Cancer. 14:419–429.
   PubMed Web of Science ®Google Scholar
• Greim H, Hartwig A, Reuter U, Richter-Reichhelm HB, Thielmann HW. 2009. Chemically induced pheochromocytomas in rats: mechanisms and relevance for human risk assessment. Crit Rev Toxicol. 39:695–718.
   PubMed Web of Science ®Google Scholar
• Guerriero JL, Ditsworth D, Catanzaro JM, Sabino G, Furie MB, Kew RR, Crawford HC, Zong W. 2011. DNA alkylating therapy induces tumor regression through an HMGB1-mediated activation of innate immunity. J Immunol. 186:3517–3526.
   PubMed Web of Science ®Google Scholar
• Gurkalo VK, Volfson NI. 1982. Nicotine influence upon the development of experimental stomach tumors. Arch Geschwulstforsch. 52:259–265.
   PubMedGoogle Scholar
• Habs M, Schmähl D. 1976. Influence of five different postnatal lifelong treatments on the transplacental carcinogenicity of ethylnitrosourea in Sprague–Dawley rats. Cancer Lett. 2:93–100.
   PubMed Web of Science ®Google Scholar
• Habs M, Schmähl D. 1984. Influence of nicotine on N-nitrosomethylurea-induced mammary tumors in rats. Klin Wochenschr. 62: 105–108.
   PubMedGoogle Scholar
• Han Y, Ling MT, Mao H, Zheng J, Liu M, Lam KT, Liu Y, Tu W, Lau YL. 2014. Influenza virus-induced lung inflammation was modulated by cigarette smoke exposure in mice. PLoS One. 9:e86166.
   Google Scholar
• Hao J, Shi FD, Abdelwahab M, Shi SX, Simard A, Whiteaker P, Lukas R, Zhou Q. 2013. Nicotinic receptorβ2 determines NK cell-dependent metastasis in a murine model of metastatic lung cancer. PLoS One. 8:e57495.
   Google Scholar
• Haussmann H-J, Gerstenberg B, Göcke W, Kuhl P, Schepers G, Stabbert R, Stinn W, Teredesai A, Tewes FJ. 1998. 12-Month inhalation study on room-aged cigarette sidestream smoke in rats. Inhal Toxicol. 10:663–697.
   Web of Science ®Google Scholar
• Hayashi S, Hamada T, Zaidi SF, Oshiro M, Lee J, Yamamoto T, Ishii Y, Sasahara M, Kadowaki M. 2014. Nicotine suppresses acute colitis and colonic tumorigenesis associated with chronic colitis in mice. Am J Physiol Gastrointest Liver Physiol. 307:G968–G978.
   PubMed Web of Science ®Google Scholar
• Hecht SS. 2012a. Research opportunities related to establishing standards for tobacco products under the Family Smoking Prevention and Tobacco Control Act. Nicotine Tob Res. 14:18–28.
   PubMed Web of Science ®Google Scholar
• Hecht SS. 2012b. Lung carcinogenesis by tobacco smoke. Int J Cancer. 131:2724–2732.
   PubMed Web of Science ®Google Scholar
• Hecht SS, Rivenson A, Braley J, Di Bello J, Adams JD, Hoffmann D. 1986. Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. Cancer Res. 46:4162–4166.
   PubMed Web of Science ®Google Scholar
• Heeschen C, Jang JJ, Weis M, Pathak A, Kaji S, Hu RS, Tsao PS, Johnson FL, Cooke JP. 2001. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med. 7:833–839.
   PubMed Web of Science ®Google Scholar
• Hermann PC, Sancho P, Cañamero M, Martinelli P, Madriles F, Michl P, Gress T, de Pascual R, Gandia L, Guerra C, et al. 2014. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice. Gastroenterology. 147:1119–1133.
   PubMed Web of Science ®Google Scholar
• Hill AB. 1965. The environment and disease: association or causation? Proc R Soc Med. 58:295–300.
   PubMed Web of Science ®Google Scholar
• Hoffmann D, Adams JD, Lisk D, Fisenne I, Brunnemann KD. 1987. Toxic and carcinogenic agents in dry and moist snuff. J Natl Cancer Inst. 79:1281–1286.
   PubMedGoogle Scholar
• Hueper WC. 1943. Experimental studies in cardiovascular pathology. VII. Chronic nicotine poisoning in rats and dogs. Arch Pathol. 35:846–856.
   Google Scholar
• Hukkanen J, Jacob III P, Benowitz NL. 2005.Metabolism and disposition kinetics of nicotine. Pharmacol Rev. 57:79–115.
   PubMed Web of Science ®Google Scholar
• Improgo MR, Soll LG, Tapper AR, Gardner PD. 2013. Nicotinic acetylcholine receptors mediate lung cancer growth. Front Physiol. 4:1–6. doi: 10.3389/fphys.2013.00251.
   PubMed Web of Science ®Google Scholar
• Improgo M, Tapper AR, Gardner PD. 2011. Nicotinic acetylcholine receptor-mediated mechanisms in lung cancer. Biochem Pharmacol. 82:1015–1021.
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer. 2007. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 89, Smokeless Tobacco and Some Tobacco-specific N-Nitrosamines. Lyon, France: World Health Organization.
   Google Scholar
• International Agency for Research on Cancer. 2012. A Review of Human Carcinogens, Part E: Personal Habits and Indoor Combustions. [cited 2015 Mar 26]. Available from: http://monographs.iarc.fr/ENG/Monographs/vol100E/mono100E.pdf/.
   Google Scholar
• Iskandar AR, Liu C, Smith DE, Hu KQ, Choi SW, Ausman LM, Wang XD. 2013. β-Cryptoxanthin restores nicotine-reduced lung SIRT1 to normal levels and inhibits nicotine-promoted lung tumorigenesis and emphysema in A/J mice. Cancer Prev Res(Phila). 6:309–320.
   PubMed Web of Science ®Google Scholar
• Ito N, Fukushima S, Shirai T, Hagiwara A, Imaida K. 1984. Drugs, food additives and natural products as promoters in rat urinary bladder carcinogenesis. IARC Sci Publ. 56:399–407.
   PubMedGoogle Scholar
• Jarvis M, Tunstall-Pedoe H, Feyerabend C, Vesey C, Salloojee Y. 1984. Biochemical markers of smoke absorption and self reported exposure to passive smoking. J Epidemiol Community Health. 38:335–339.
   PubMed Web of Science ®Google Scholar
• Jarzynka MJ, Guo P, Bar-Joseph I, Hu B, Cheng SY. 2006. Estradiol and nicotine exposure enhances A549 bronchioloalveolar carcinoma xenograft growth in mice through the stimulation of angiogenesis. Int J Oncol. 28:337–344.
   PubMed Web of Science ®Google Scholar
• Jensen K, Afroze S, Munshi MK, Guerrier M, Glaser SS. 2012. Mechanisms for nicotine in the development and progression of gastrointestinal cancers. Transl Gastrointest Cancer. 1:81–87.
   PubMedGoogle Scholar
• Kalra R, Singh SP, Pena-Philippides JC, Langley RJ, Razani-Boroujerdi S, Sopori ML. 2004. Immunosuppressive and anti-inflammatory effects of nicotine administered by patch in an animal model. Clin Diagn Lab Immunol. 11:563–568.
   PubMedGoogle Scholar
• Khalil AA, Jameson MJ, Broaddus WC, Lin PS, Chung TD. 2013. Nicotine enhances proliferation, migration, and radioresistance of human malignant glioma cells through EGFR activation. Brain Tumor Pathol. 30:73–83.
   PubMed Web of Science ®Google Scholar
• Klaunig JE. 2013. Chapter 8: chemical carcinogenesis. In: Klaassen CD, editor. Casarett and Doull's toxicology: the basic science of poison. New York: McGraw-Hill.
   Google Scholar
• Kleinsasser NH, Sassen AW, Semmler MP, Harreus UA, Licht AK, Richter E. 2005. The tobacco alkaloid nicotine demonstrates genotoxicity in human tonsillar tissue and lymphocytes. Toxicol Sci. 86:309–317.
   PubMed Web of Science ®Google Scholar
• Klier U, Maletzki C, Gottmann N, Kreikemeyer B, Linnebacher M. 2011. Avitalized bacteria mediate tumor growth control via activation of innate immunity. Cell Immunol. 269:120–127.
   PubMed Web of Science ®Google Scholar
• Klimisch HJ, Andreae M, Tillmann U. 1997. A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. Regul Toxicol Pharmacol. 25:1–5.
   PubMed Web of Science ®Google Scholar
• Kosdoba AS. 1930. Zur Frage der experimentellen Pathologie der Nebennieren bei intravenöser Nicotineinverleibung [On the question of experimental pathology of the adrenals upon intravenous nicotine application]. Arch Klin Chir. 156:550–566.
   Google Scholar
• Kyerematen GA, Taylor LH, de Bethizy JD, Vesell ES. 1988. Pharmacokinetics of nicotine and 12 metabolites in the rat. Application of a new radiometric high performance liquid chromatography assay. Drug Metab Dispos. 16:125–129.
   PubMed Web of Science ®Google Scholar
• Lam DC, Luo SY, Fu KH, Lui MM, Chan KH, Wistuba II, Gao B, Tsao SW, Ip MS, Minna JD. 2016. Nicotinic acetylcholine receptor expression in human airway correlates with lung function. Am J Physiol Lung Cell Mol Physiol. 310:L232–L239.
   Google Scholar
• Landau JM, Wang ZY, Yang GY, Ding W, Yang CS. 1998. Inhibition of spontaneous formation of lung tumors and rhabdomyosarcomas in A/J mice by black and green tea. Carcinogenesis. 19:501–507.
   PubMed Web of Science ®Google Scholar
• Larson PS, Haag HB, Silvette H. 1961. Tobacco – experimental and clinical studies, a comprehensive account of the world literature. Baltimore (MD): The Williams & Wilkins Company.
   Google Scholar
• La Voie EJ, Shigematsu A, Rivenson A, Mu B, Hoffmann D. 1985. Evaluation of the effects of cotinine and nicotine-N'-oxides on the development of tumors in rats initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. J Natl Cancer Inst. 75:1075–1081.
   PubMedGoogle Scholar
• Lee CH, Huang CS, Chen CS, Tu SH, Wang YJ, Chang YJ, Tam KW, Wei PL, Cheng TC, Chu JS, et al. 2010. Overexpression and activation of the alpha9-nicotinic receptor during tumorigenesis in human breast epithelial cells. J Natl Cancer Inst. 102:1322–1335.
   PubMedGoogle Scholar
• Lee CH, Wu CH, Ho YS. 2011. From smoking to cancers: novel targets to neuronal nicotinic acetylcholine receptors. J Oncol. 2011:693424.
   PubMedGoogle Scholar
• Lee J, Cooke JP. 2012. Nicotine and pathological angiogenesis. Life Sci. 91:1058–1064.
   PubMed Web of Science ®Google Scholar
• Levy LS, Martin PA. 1989. Toxicology of nicotine – its role in the aetiology of cancer due to cigarette smoking and cardiovascular disease. In: Wald N, Froggatt P, editors. Nicotine, smoking, and the low tar programme. Oxford: Oxford University Press. p. 11–23.
   Google Scholar
• Li H, Wang S, Takayama K, Harada T, Okamoto I, Iwama E, Fujii A, Ota K, Hidaka N, Kawano Y, et al. 2015. Nicotine induces resistance to erlotinib via cross-talk between α 1 nAChR and EGFR in the non-small cell lung cancer xenograft model. Lung Cancer. 88:1–8.
   PubMed Web of Science ®Google Scholar
• Liu D, Pan F, Li B, Han X, Li W, Shi Y, Pang Z, Zhang Q. 2011. Intervention of nicotine on MNU-induced bladder cancer in rats. J Huazhong Univ Sci Technol Med Sci. 31:103–106.
   PubMed Web of Science ®Google Scholar
• Liu W, Yi DD, Guo JL, Xiang ZX, Deng LF, He L. 2015. Nuciferine, extracted from Nelumbo nucifera Gaertn, inhibits tumor-promoting effect of nicotine involving Wnt/β-catenin signaling in non-small cell lung cancer. J Ethnopharmacol. 165:83–93.
   PubMed Web of Science ®Google Scholar
• Maier CR, Hollander MC, Hobbs EA, Dogan I, Linnoila RI, Dennis PA. 2011. Nicotine does not enhance tumorigenesis in mutant K-ras-driven mouse models of lung cancer. Cancer Prev Res(Phila). 4:1743–1751.
   PubMed Web of Science ®Google Scholar
• Manenti G, Dragani TA. 2005. Pas1 haplotype-dependent genetic predisposition to lung tumorigenesis in rodents: a meta-analysis. Carcinogenesis. 26:875–882.
   PubMed Web of Science ®Google Scholar
• Marks MJ, Stitzel JA, Collins AC. 1985. Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. J Pharmacol Exp Ther. 235:619–628.
   PubMed Web of Science ®Google Scholar
• Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, Craig CR, Collins AC, Damaj MI, Donny EC, et al. 2007. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berlin). 190:269–319.
   PubMed Web of Science ®Google Scholar
• Mauderly JL, Bechtold WE, Bond JA, Brooks AL, Chen BT, Cuddihy RG, Harkema JR, Henderson RF, Johnson NF, Rithidech K. 1989. Comparison of 3 methods of exposing rats to cigarette smoke. Exp Pathol. 37:194–197.
   PubMedGoogle Scholar
• Molfino A, Logorelli F, Citro G, Bertini G, Ramaccini C, Bollea MR, Rossi FF, Laviano A. 2011. Stimulation of the nicotine antiinflammatory pathway improves food intake and body composition in tumor-bearing rats. Nutr Cancer. 63:295–299.
   PubMed Web of Science ®Google Scholar
• Moolgavkar SH, Knudson AGJ. 1981. Mutation and cancer: a model for human carcinogenesis. J Natl Cancer Inst. 66:1037–1052.
   PubMedGoogle Scholar
• Murphy SE, von Weymarn LB, Schutten MM, Kassie F, Modiano JF. 2011. Chronic nicotine consumption does not influence 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis. Cancer Prev Res (Phila). 4:1752–1760.
   PubMed Web of Science ®Google Scholar
• Murray RP, Connett JE, Zapawa LM. 2009. Does nicotine replacement therapy cause cancer? Evidence from the Lung Health Study. Nicotine Tob Res. 11:1076–1082.
   PubMed Web of Science ®Google Scholar
• Nakada T, Kiyotani K, Iwano S, Uno T, Yokohira M, Yamakawa K, Fujieda M, Saito T, Yamazaki H, Imaida K, et al. 2012. Lung tumorigenesis promoted by anti-apoptotic effects of cotinine, a nicotine metabolite through activation of PI3K/Akt pathway. J Toxicol Sci. 37:555–563.
   PubMed Web of Science ®Google Scholar
• Natori T, Sata M, Washida M, Hirata Y, Nagai R, Makuuchi M. 2003. Nicotine enhances neovascularization and promotes tumor growth. Mol Cells. 16:143–146.
   PubMed Web of Science ®Google Scholar
• Nishikawa A, Furukawa F, Imazawa T, Yoshimura H, Mitsumori K, Takahashi M. 1992. Effects of caffeine, nicotine, ethanol and sodium selenite on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine. Carcinogenesis. 13:1379–1382.
   PubMed Web of Science ®Google Scholar
• Niu XM, Lu S. 2014. Acetylcholine receptor pathway in lung cancer: new twists to an old story. World J Clin Oncol. 5:667–676.
   PubMedGoogle Scholar
• Organisation for Economic Co-operation and Development. 2009. OECD guideline for the testing of chemicals. 451 Carcinogenicity studies. Paris: OECD Publishing.
   Google Scholar
• Paleari L, Catassi A, Ciarlo M, Cavalieri Z, Bruzzo C, Servent D, Cesario A, Chessa L, Cilli M, Piccardi F, et al. 2008. Role of alpha7-nicotinic acetylcholine receptor in human non-small cell lung cancer proliferation. Cell Prolif. 41:936–959.
   PubMed Web of Science ®Google Scholar
• Petersen DR, Norris KJ, Thompson JA. 1984. A comparative study of the disposition of nicotine and its metabolites in three inbred strains of mice. Drug Metab Dispos. 12:725–731.
   PubMed Web of Science ®Google Scholar
• Pietilä K, Laakso I, Ahtee L. 1995. Chronic oral nicotine administration affects the circadian rhythm of dopamine and 5-hydroxytryptamine metabolism in the striata of mice. Naunyn Schmiedebergs Arch Pharmacol. 353:110–115.
   PubMed Web of Science ®Google Scholar
• Pillai S, Trevino J, Rawal B, Singh S, Kovacs M, Li X, Schell M, Haura E, Bepler G, Chellappan S. 2015. β-Arrestin-1 mediates nicotine-induced metastasis through E2F1 target genes that modulate epithelial–mesenchymal transition. Cancer Res. 75:1009–1020.
   PubMed Web of Science ®Google Scholar
• Pratesi G, Cervi S, Balsari A, Bondiolotti G, Vicentini LM. 1996. Effect of serotonin and nicotine on the growth of a human small cell lung cancer xenograft. Anticancer Res. 16:3615–3619.
   PubMed Web of Science ®Google Scholar
• Prokopczyk G, Adams JD, La Voie EJ, Hoffmann D. 1987. Effect of snuff and nicotine on DNA methylation by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis. 8:1395–1397.
   PubMed Web of Science ®Google Scholar
• Prueitt RL, Lynch HN, Zu K, Sax SN, Venditti FJ, Goodman JE. 2014. Weight-of-evidence evaluation of long-term ozone exposure and cardiovascular effects. Crit Rev Toxicol. 44:791–822.
   PubMed Web of Science ®Google Scholar
• Rana MW, Bhagat B. 1970. Chemical carcinogenesis in immunosympathectomized mice. Anat Rec. 166:365.
   Google Scholar
• Renda A, Nashmi R. 2014. Chronic nicotine pretreatment is sufficient to upregulate α4 nicotinic receptors and increase oral nicotine self-administration in mice. BMC Neurosci. 15:89.
   PubMed Web of Science ®Google Scholar
• Rhomberg LR, Bailey LA, Goodman JE, Hamade AK, Mayfield D. 2011. Is exposure to formaldehyde in air causally associated with leukemia? – a hypothesis-based weight-of-evidence analysis. Crit Rev Toxicol. 41:555–621.
   PubMed Web of Science ®Google Scholar
• Rhomberg LR, Goodman JE, Bailey LA, Prueitt RL, Beck NB, Bevan C, Honeycutt M, Kaminski NE, Paoli G, Pottenger LH, et al. 2013. A survey of frameworks for best practices in weight-of-evidence analyses. Crit Rev Toxicol. 43:753–784.
   PubMed Web of Science ®Google Scholar
• Rubin H. 2001. Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: a bio-historical perspective with updates. Carcinogenesis. 22:1903–1930.
   PubMed Web of Science ®Google Scholar
• Rubin H. 2002. Selective clonal expansion and microenvironmental permissiveness in tobacco carcinogenesis. Oncogene. 21:7392–7411.
   PubMed Web of Science ®Google Scholar
• Russo P, Cardinale A, Margaritora S, Cesario A. 2012. Nicotinic receptor and tobacco-related cancer. Life Sci. 91:1087–1092.
   PubMed Web of Science ®Google Scholar
• Sanner T, Grimsrud TK. 2015. Nicotine: carcinogenicity and effects on response to cancer treatment-a review. Front Oncol. 5:196.
   PubMed Web of Science ®Google Scholar
• Schaal C, Chellappan SP. 2014. Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers. Mol Cancer Res. 12:14–23.
   PubMed Web of Science ®Google Scholar
• Schepers G, Rustemeier K, Walk RA, Hackenberg U. 1993. Metabolism of S-nicotine in noninduced and aroclor-induced rats. Eur J Drug Metab Pharmacokinet. 18:187–197.
   PubMed Web of Science ®Google Scholar
• Schievelbein H. 1962. Nikotin, Rauchen und Organismus [Nicotine, smoking and organism]. Beitr Tabakforsch Int. 1:199–274.
   Google Scholar
• Schmähl D, Habs M. 1976. Life-span investigations for carcinogenicity of some immune-stimulating, immunodepressive and neurotropic substances in Sprague–Dawley rats. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 86:77–84.
   PubMedGoogle Scholar
• Schmähl D, Osswald H. 1968. Fehlen einer carcinogenen Wirkung von Cotinin bei Ratten [Lack of a carcinogenic effect of cotinine in rats]. Zeitschrift Für Krebsforschung. 71:198.
   Google Scholar
• Schneider NG, Olmstead RE, Franzon MA, Lunell E. 2001. The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments. Clin Pharmacokinet. 40:661–684.
   PubMed Web of Science ®Google Scholar
• Schoental R, Head MA. 1953. Tobacco alkaloids. In: 31st Annual Report. British Empire Cancer Campaign; p. 269.
   Google Scholar
• Schuller HM. 2012. Regulatory role of the α7nAChR in cancer. Curr Drug Targets. 13:680–687.
   PubMed Web of Science ®Google Scholar
• Schuller HM. 2014. Impact of neuro-psychological factors on smoking-associated lung cancer. Cancers (Basel). 6:580–594.
   PubMedGoogle Scholar
• Schuller HM, McGavin MD, Orloff M, Riechert A, Porter B. 1995. Simultaneous exposure to nicotine and hyperoxia causes tumors in hamsters. Lab Invest. 73:448–456.
   PubMed Web of Science ®Google Scholar
• Shahab L, Brose LS, West R. 2013. Novel delivery systems for nicotine replacement therapy as an aid to smoking cessation and for harm reduction: rationale, and evidence for advantages over existing systems. CNS Drugs. 27:1007–1019.
   PubMed Web of Science ®Google Scholar
• Shields PG. 2011. Long-term nicotine replacement therapy: cancer risk in context. Cancer Prev Res(Phila). 4:1719–1723.
   PubMed Web of Science ®Google Scholar
• Shin VY, Wu WK, Ye YN, So WH, Koo MW, Liu ES, Luo JC, Cho CH. 2004. Nicotine promotes gastric tumor growth and neovascularization by activating extracellular signal-regulated kinase and cyclooxygenase-2. Carcinogenesis. 25:2487–2495.
   PubMed Web of Science ®Google Scholar
• Shultz LD, Goodwin N, Ishikawa F, Hosur V, Lyons BL, Greiner DL. 2014. Human cancer growth and therapy in immunodeficient mouse models. Cold Spring Harbor Protocol. 2014:694–708.
   PubMedGoogle Scholar
• Singh S, Pillai S, Chellappan S. 2011. Nicotinic acetylcholine receptor signaling in tumor growth and metastasis. J Oncol. 2011:456743.
   PubMedGoogle Scholar
• Siu ECK, Tyndale RF. 2007. Characterization and comparison of nicotine and cotinine metabolism in vitro and in vivo in DBA/2 and C57BL/6 mice. Mol Pharmacol. 71:826–834.
   PubMed Web of Science ®Google Scholar
• Sparks JA, Pauly JR. 1999. Effects of continuous oral nicotine administration on brain nicotinic receptors and responsiveness to nicotine in C57Bl/6 mice. Psychopharmacology (Berl). 141:145–153.
   PubMed Web of Science ®Google Scholar
• Staemmler M. 1935. Die chronische Vergiftung mit Nicotin. Ergebnisse experimenteller Untersuchungen an Ratten [Chronic poisoning with nicotine. Results of experimental studies in rats]. Vichows Archiv. 295:366–393.
   Google Scholar
• Staemmler M. 1936. Über geschwulstartige Bildungen im Nebennierenmark als Folge experimenteller Nicotinvergiftungen [Tumor-like developments in the adrenal medulla as a consequence of experimental nicotine poisoning]. Klin Wochenschr. 15:404–407.
   Google Scholar
• Stinn W, Berges A, Meurrens K, Buettner A, Gebel S, Lichtner RB, Janssens K, Veljkovic E, Xiang Y, Roemer E, et al. 2013. Towards the validation of a lung tumorigenesis model with mainstream cigarette smoke inhalation using the A/J mouse. Toxicology. 305:49–64.
   PubMed Web of Science ®Google Scholar
• Stoner GD, Shimkin MB. 1982. Strain A mouse lung tumor assay. J Am Coll Toxicol. 1:145–169.
   Google Scholar
• Theophilus EH, Hayes JR, Potts RJ, Ayres PH, Williams CD, Garner CD. 2012. Toxicological evaluation of smokeless tobacco: 90-day rodent feeding studies. Exp Toxicol Pathol. 64:15–24.
   PubMed Web of Science ®Google Scholar
• Thienes CH. 1960. Chronic nicotine poisoning. Ann N Y Acad Sci. 90:239–248.
   PubMed Web of Science ®Google Scholar
• Thompson JG, Irwin FD, Kanematsu S, Seraydarian K, Suh M. 1973. Effects of chronic nicotine administration and age in male Fischer-344 rats. Toxicol Appl Pharmacol. 26:606–620.
   PubMed Web of Science ®Google Scholar
• Toth B. 1982. Effects of long term administration of nicotine hydrochloride and nicotinic acid in mice. Anticancer Res. 2:71–73.
   PubMed Web of Science ®Google Scholar
• Treviño JG, Pillai S, Kunigal S, Singh S, Fulp WJ, Centeno BA, Chellappan SP. 2012. Nicotine induces inhibitor of differentiation-1 in a Src-dependent pathway promoting metastasis and chemoresistance in pancreatic adenocarcinoma. Neoplasia. 14:1102–1114.
   PubMed Web of Science ®Google Scholar
• Truhaut R, De Clercq M. 1961. Sur le rôle éventuel de la nicotine et de ses dérivés de pyrogénation dans les phénomènes de cancérisation [On the eventual role of nicotine and its derivatives of pyrogenation in the phenomena of canceration]. C R Hebd Seances Acad Sci. 253:1506–1508.
   PubMedGoogle Scholar
• Truhaut R, De Clercq M, Loisillier F. 1964. Sur les toxicitès aiguë et chronique de la cotinine, et sur son effet cancérigène chez le rat [On the acute and chronic toxicity of cotinine, and on its cancerogenic effect in the rat]. Pathol Biol (Paris). 12:39–42.
   PubMedGoogle Scholar
• UK Royal College of Physicians. 2007. Harm reduction in nicotine addiction. Helping people who can't quit. [cited 2015 Jun 16]. Available from: http://www.tobaccoprogram.org/pdf/4fc74817-64c5-4105-951e-38239b09c5db.pdf/.
   Google Scholar
• US Department of Health and Human Services. 2014. The health consequences of smoking – 50 years of progress. A report of the Surgeon General. [cited 2015 Jun 16]. Available from: http://www.surgeongeneral.gov/library/reports/50-years-of-progress/full-report.pdf/.
   Google Scholar
• US Food and Drug Administration. 2013. Modifications to labeling of nicotine replacement therapy products for over-the-counter human use. Fed Regist. 78:19718–19721.
   Google Scholar
• US Food and Drug Administration. 2015. Drugs@FDA, Nicorette. [cited 2016 Mar 7]. Available from: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm/.
   Google Scholar
• von Otto C. 1911. Über anatomische Veränderungen des Herzens infolge von Nikotin (Experimentalstudie) [About anatomical changes of the heart due to nicotine (experimental study)]. Arch Path Anat. 205:384–397.
   Google Scholar
• Waldum HL, Nilsen OG, Nilsen T, Rørvik H, Syversen U, Sandvik AK, Haugen OA, Torp SH, Brenna E. 1996. Long-term effects of inhaled nicotine. Life Sci. 58:1339–1346.
   PubMed Web of Science ®Google Scholar
• Warren GW, Singh AK. 2013. Nicotine and lung cancer. J Carcinog. 12:1.
   PubMedGoogle Scholar
• Warren GW, Romano MA, Kudrimoti MR, Randall ME, McGarry RC, Singh AK, Rangnekar VM. 2012. Nicotinic modulation of therapeutic response in vitro and in vivo. Int J Cancer. 131:2519–2527.
   PubMed Web of Science ®Google Scholar
• Werley MS, Jerome AM, Oldham MJ. 2014. Toxicological evaluation of aerosols of a tobacco extract formulation and nicotine formulation in acute and short-term inhalation studies. Inhal Toxicol. 26:207–221.
   PubMed Web of Science ®Google Scholar
• Willhite CC, Karyakina NA, Yokel RA, Yenugadhati N, Wisniewski TM, Arnold IM, Momoli F, Krewski D. 2014. Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts. Crit Rev Toxicol. 44:1–80.
   PubMed Web of Science ®Google Scholar
• Wilson RH, De Eds F. 1936. Chronic nicotine toxicity: I. Feeding of nicotine sulfate, tannate, and bentonite. J Ind Hyg Toxicol. 18:553–564.
   Google Scholar
• Wilson RH, McNaught JB, De Eds F. 1938. Chronic nicotine toxicity: IV. Effect of nicotine-containing diets on histology and weights of organs of albino rats. J Ind Hyg Toxicol. 20:468–481.
   Google Scholar
• Wong HPS, Yu L, Lam EKY, Tai EKK, Wu WKK, Cho CH. 2007. Nicotine promotes colon tumor growth and angiogenesis through β-adrenergic activation. Toxicol Sci. 97:279–287.
   PubMed Web of Science ®Google Scholar
• Ye YN, Liu ES, Shin VY, Wu WK, Luo JC, Cho CH. 2004. Nicotine promoted colon cancer growth via epidermal growth factor receptor, c-Src, and 5-lipoxygenase-mediated signal pathway. J Pharmacol Exp Ther. 308:66–72.
   PubMed Web of Science ®Google Scholar
• Yokohira M, Nakano Y, Hashimoto N, Yamakawa K, Ninomiya F, Kishi S, Saoo K, Imaida K. 2012. Toxicity of nicotine by repeated intratracheal instillation to F344 rats. J Toxicol Pathol. 25:257–263.
   PubMed Web of Science ®Google Scholar
• Yu CC, Chang YC. 2013. Enhancement of cancer stem-like and epithelial-mesenchymal transdifferentiation property in oral epithelial cells with long-term nicotine exposure: reversal by targeting SNAIL. Toxicol Appl Pharmacol. 266:459–469.
   PubMed Web of Science ®Google Scholar
• Yu MA, Kiang A, Wang-Rodriguez J, Rahimy E, Haas M, Yu V, Ellies LG, Chen J, Fan JB, Brumund KT, et al. 2012. Nicotine promotes acquisition of stem cell and epithelial-to-mesenchymal properties in head and neck squamous cell carcinoma. PLoS One. 7:e51967.
   PubMed Web of Science ®Google Scholar
• Yuge K, Kikuchi E, Hagiwara M, Yasumizu Y, Tanaka N, Kosaka T, Miyajima A, Oya M. 2015. Nicotine induces tumor growth and chemoresistance through activation of the PI3K/Akt/mTOR pathway in bladder cancer. Mol Cancer Ther. 14:2112–2120.
   PubMed Web of Science ®Google Scholar
• Yun IS, Kim SS. 1938. Influence of continuous subcutaneous injection of nicotine on adrenal gland and anterior lobe of hypophysis. Trans Jap Pathol Soc. 28:426–428.
   Google Scholar
• Zhou P, Ma B, He W, Xu D, Wang X. 2011. CpG oligodeoxynucleotide stimulates protective innate immunity against human renal cell carcinoma xenografted in nude mice. J Immunother. 34:535–541.
   PubMed Web of Science ®Google Scholar